美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=JUVISYNC"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
JUVISYNC 202343 001 NDA SIMVASTATIN; SITAGLIPTIN PHOSPHATE TABLET;ORAL 10MG;EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Yes No 2011/10/07 2011/10/07 MERCK SHARP DOHME Discontinued
JUVISYNC 202343 002 NDA SIMVASTATIN; SITAGLIPTIN PHOSPHATE TABLET;ORAL 20MG;EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Yes No 2011/10/07 2011/10/07 MERCK SHARP DOHME Discontinued
JUVISYNC 202343 003 NDA SIMVASTATIN; SITAGLIPTIN PHOSPHATE TABLET;ORAL 40MG;EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Yes No 2011/10/07 2011/10/07 MERCK SHARP DOHME Discontinued
JUVISYNC 202343 004 NDA SIMVASTATIN; SITAGLIPTIN PHOSPHATE TABLET;ORAL 10MG;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Yes No 2011/10/07 2012/09/18 MERCK SHARP DOHME Discontinued
JUVISYNC 202343 005 NDA SIMVASTATIN; SITAGLIPTIN PHOSPHATE TABLET;ORAL 20MG;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Yes No 2011/10/07 2012/09/18 MERCK SHARP DOHME Discontinued
JUVISYNC 202343 006 NDA SIMVASTATIN; SITAGLIPTIN PHOSPHATE TABLET;ORAL 40MG;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Yes No 2011/10/07 2012/09/18 MERCK SHARP DOHME Discontinued
药品名称,活性成分,申请号搜索 高级检索
©2006-2019 DrugFuture->U.S. FDA Drugs Database